2.56 USD
↘ 0.00 (0.20%)PRE MARKET (AS OF 04:04 AM EDT)
OnKure Therapeutics, Inc. Class A Common Stock
OKURNASDAQ • USD
Market: OPEN
Shares of OnKure Therapeutics, Inc. Class A Common Stock (OKUR) are trading at $2.56. Our models show a "Strong Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, OKUR appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 2, 2026.
Open?$2.56
High?$2.56
Low?$2.56
Prev. Close?$2.56
Volume?100
Avg. Volume?276.3K
VWAP?$2.56
Rel. Volume?0.00x
Bid / Ask
Bid?$2.04 × 100
Ask?$2.95 × 100
Spread?$0.91
Midpoint?$2.50
Valuation & Ratios
Market Cap?103.7M
Shares Out?40.4M
Float?24.9M
Float %?61.7%
P/E Ratio?N/A
P/B Ratio?0.60
EPS?-$1.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Employees
45
Market Cap
103.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2024-10-07
Address
6707 WINCHESTER CIRCLE, SUITE 400
BOULDER, CO 80301
Phone: (720) 307-2892
BOULDER, CO 80301
Phone: (720) 307-2892
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?65
Short Sent.?42
Piotroski F-Score?0/9Weak
Altman Z-Score?6.68Safe
Confidence?36%Very Low
Short InterestHigh
Short % of Float?5.52%Elevated
Short Interest?1.4M
Days to Cover?9.3
Free Float24.9M
Avg Daily Volume148.2K
Settlement Date2026-09-15
Financial Health
Current Ratio?26.75Strong
Quick Ratio?26.75Strong
Cash Ratio?25.06Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.60CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?1.0CHEAP▾
Peers100
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-34.1%WEAK▾
S&P5
ROA?-32.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-47864000
Enterprise Value?$-62831449
Fundamentals ratios updated end of day